CA Stock MarketDetailed Quotes
MDCX Medicus Pharma Ltd
- 1.500
- -0.210-12.28%
15min DelayMarket Closed Jul 2 16:00 ET
24.23MMarket Cap-2212P/E (TTM)
1.710High1.500Low3.70KVolume1.710Open1.710Pre Close5.95KTurnover3.05052wk High0.07%Turnover Ratio16.15MShares0.31052wk Low-0.678EPS TTM7.90MFloat Cap3.050Historical HighLossP/E (Static)5.26MShs Float0.310Historical Low-1.286EPS LYR12.28%Amplitude--Dividend TTM-28.85P/B1Lot Size--Div YieldTTM
Medicus Pharma Ltd Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -391.30%-1.18M | -293.36%-4.16M | -926.35%-3.39M | 15.41%-148.58K | -63.92%-381.52K | 24.80%-239.56K | 27.00%-1.06M | -330.16K | -175.64K | -232.75K |
| Net income from continuing operations | -270.21%-1.79M | -300.86%-6.78M | -783.84%-2.85M | -664.25%-2.96M | 2.08%-488.67K | -0.12%-483.92K | 17.66%-1.69M | ---322.21K | ---387.79K | ---499.05K |
| Depreciation and amortization | --26.04K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | --69.83K | --146.67K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non cashItems | -88.93%9.01K | 131.17%1.65M | --0 | 1,047.54%1.34M | -2.96%232.98K | -62.23%81.39K | 16.30%713.97K | --141.95K | --116.43K | --240.08K |
| Change In working capital | 212.75%509.72K | 1,153.22%828.74K | -358.61%-687.42K | 1,445.12%1.48M | -570.09%-125.83K | 2,940.31%162.98K | -1,081.84%-78.69K | ---149.89K | --95.72K | ---18.78K |
| -Change in prepaid assets | 753.07%61.64K | -958.13%-158.72K | -1,056.67%-173.5K | --7.56K | --0 | --7.23K | ---15K | ---15K | --0 | --0 |
| -Change in payables and accrued expense | 187.69%448.08K | 1,650.49%987.46K | -280.98%-513.92K | 1,437.23%1.47M | -570.09%-125.83K | 2,814.38%155.75K | -856.55%-63.69K | ---134.89K | --95.72K | ---18.78K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -391.30%-1.18M | -293.36%-4.16M | -926.35%-3.39M | 15.41%-148.58K | -37.36%-381.52K | 12.43%-239.56K | 27.00%-1.06M | ---330.16K | ---175.64K | ---277.75K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 350.15%5.61M | 0 | 10,119.90%5.11M | 41.24%1.25M | 591.33K | 50K | 0 | |||
| Net issuance payments of debt | ---- | -59.88%500K | --0 | --0 | ---- | ---- | 41.24%1.25M | --591.33K | --50K | --0 |
| Net other financing activities | ---- | --5.11M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | 350.15%5.61M | --0 | 10,119.90%5.11M | ---- | ---- | 41.24%1.25M | --591.33K | --50K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 542.38%1.72M | 240.90%267.65K | 78,726.31%5.11M | 10.94%146.57K | -93.15%28.1K | 240.90%267.65K | -87.81%78.51K | --6.48K | --132.12K | --409.86K |
| Current changes in cash | -391.30%-1.18M | 667.53%1.45M | -1,397.46%-3.39M | 4,049.01%4.96M | 142.66%118.48K | -172.30%-239.56K | 133.44%189.14K | --261.17K | ---125.64K | ---277.75K |
| End cash Position | 1,830.54%542.41K | 542.38%1.72M | 542.38%1.72M | 78,726.31%5.11M | 10.94%146.57K | -93.15%28.1K | 240.90%267.65K | --267.65K | --6.48K | --132.12K |
| Free cash from | -391.30%-1.18M | -293.36%-4.16M | -926.35%-3.39M | 15.41%-148.58K | -37.36%-381.52K | 12.43%-239.56K | 27.00%-1.06M | ---330.16K | ---175.64K | ---277.75K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg